The Patent Finder
US

Pazopanib Formulation

US 9,278,099 In force
OverviewFamilyAssignmentsSources & methods

Also listed on Leo Osprey Limited, an earlier holder on the record. The recorded assignments below show how it moved.

Term ends Oct 16, 2032 · High confidence

Held by Novartis AG
Filed Apr 21, 2014 as application 14/353,141 · Granted Mar 8, 2016
Base term, 20 years from filing
Today
20 years from filing
2012 2032
Clock starts
Oct 16, 2012
Term ends
Oct 16, 2032
Granted
Mar 8, 2016
base term fee events Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
None
Terminal disclaimer
No disclaimer on this record.
2 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
5
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.

This patent's term is its 20-year base term, with no adjustment for prosecution delay. 2 of 3 maintenance fees are paid so far. Confidence: High. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Oct 16, 2012, when application PCT/US2012/060361, the earliest non-provisional in its chain, was filed (this one was filed Apr 21, 2014)Oct 16, 2032High confidence
Continuity chainEvery parent in the chain resolvedno changeHigh confidence
Patent term adjustmentNone on fileno changeHigh confidence
Terminal disclaimer capNone on recordno cap appliedHigh confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events2 of 3 maintenance fees paidIn forceHigh confidence
Computed term endThe steps above, in orderOct 16, 2032High confidence

This family

US 9,278,099this patent
Oct 2032
Oct 2032
US 10,080,802In force
Oct 2032
Oct 2032
US 10,596,263In force
Oct 2032
Oct 2032
3 of 5 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Jul 21, 2014
Reel 33352, frame 662
Richardson, Helen; Williams, Peter A.; Campbell, Gossett AugustusGlaxoSmithKline Intellectual Property LimitedAssignment of Assignor's Interest
Jun 2, 2015
Reel 35760, frame 185
GlaxoSmithKline Intellectual Property LimitedLeo Osprey LimitedAssignment of Assignor's Interest
Jun 3, 2015
Reel 35771, frame 154
Leo Osprey LimitedNovartis AGAssignment of Assignor's Interest

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited